The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The popularity of medical cannabinoids (MCs) treatment is growing, as more countries enable MCs treatment for various indications in adults 1. Metrics details. Introduction.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 25, 2022

To become a registered patient with legal rights to purchase medical marijuana, a state-licensed physician must determine that you would indeed benefit from this treatment. Some of the conditions that qualify for receiving medical marijuana treatment in Pennsylvania include, but are not limited to: Muscle spasticity. Anxiety disorders.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S. by the year 2027 , at which point the market could be worth a staggering $33.2 Depression.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death.

Research and Development 117

Research and Development Education Agriculture Patients 117

Freedom Leaf

OCTOBER 15, 2018

On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9 billion by 2022.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

JANUARY 13, 2020

In particular, we see significant market opportunity for nabiximols in several indications in the US and will be progressing multiple late stage clinical programs in 2020.”. Nabiximols (known as “Sativex” outside US) in the US: Commence pivotal clinical program in initial target indication of spasticity associated with Multiple Sclerosis.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Laws restricting birth control, abortion, drug use, as well as requirements to receive welfare, drug treatment and even pain medication are developed in a paternalistic nature.

Policy 96

Policy Research and Development Conditions Consumption 96

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. He took inspired action to found Groff North America after years of acknowledging the plant’s therapeutic benefits. territories. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JUNE 1, 2021

Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. Sesen Bio is currently in the follow-up stage of a Phase 3 registration trial in the US for the treatment of BCG-unresponsive NMIBC. CAMBRIDGE, Mass.–(BUSINESS

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. .’ Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

Veriheal

OCTOBER 5, 2020

The Medical Marijuana Dispensary Program of Hawaii was created in order to get medical cannabis consumers to register for consuming the plant. The program requires cannabis patients to have a licensed physician to certify that the individual would benefit from medical cannabis before they can register for it.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

NOVEMBER 26, 2019

Many unanswered questions and data gaps about CBD toxicity exist, and some of the available data raise serious concerns about potential harm from CBD. The FDA has not approved any CBD products other than one prescription human drug product to treat rare, severe forms of epilepsy. The FDA, an agency within the U.S.

Safety 64

Safety Food CBD Oil 64

Cannabis Law Report

AUGUST 5, 2019

The study, conducted the company’s digital marketing arm, LOCALiQ, combined survey responses with mobile data to paint a picture of cannabis consumers in legal states. USA Today Report: Cannabis Consumers Reduce Use of Pills, Booze. . Tilray Delivers First Cannabis Shipment For Health Checks. . Read more. . More Kroger Co.

Law 40

Law Decriminalization Hemp Legislation 40

Cannabis Law Report

FEBRUARY 17, 2020

For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. AUTHOR: Heather Allman. PUBLISHER: CANNABIS LAW REPORT. Clearing the Air- Florida Condensed Cannabis

Dispensary 76

Dispensary Patients Agriculture Conditions 76

CannaTech

OCTOBER 14, 2018

The state was well-positioned to permit this type of farming back in 2013 when Senate Bill 566 was enacted, conditionally approving an industrial hemp pilot program. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. In the U.S. One of the best examples is a recent study that led to the U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Info

JULY 12, 2019

CBD for Pets Yes the Data says it works ! When your pet gets sick, you give up everything and try to find them the best possible medicine or treatment available. Lets review some data. Since then, numerous studies have provided lots of clinical data that CBD can help manage a wide variety of tremors, spasms, and tics.

Pets 45

Pets Data CBD Cannabinoids 45

The Cannigma

SEPTEMBER 13, 2021

Also in 2020, Israel surpassed Germany as the world’s largest importer of medical cannabis flower, according to data from Israel’s online Cannabis Magazine. Foreigners cannot access Israel’s medical marijuana program, and there is no reciprocity that would allow them to bring their cannabis medicine with them when visiting.

Legalization 97

Legalization Decriminalization Patients Cannabis 97

Cannabis Law Report

NOVEMBER 15, 2021

Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. VRP324 represents our first CNS disorder product indication. RECENT DEVELOPMENTS. Bruce and Michael F.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Healer

JANUARY 17, 2022

While THC’s maximal pain reduction was better (THC had the potential for stronger relief at much higher doses), this data suggests CBG could be a cost-effective agent for pain, effective at low doses without the impairment possibility related to THC. That’s a significant reduction that could be important in the treatment for glaucoma.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Healer

JANUARY 17, 2022

While THC’s maximal pain reduction was better (THC had the potential for stronger relief at much higher doses), this data suggests CBG could be a cost-effective agent for pain, effective at low doses without the impairment possibility related to THC. That’s a significant reduction that could be important in the treatment for glaucoma.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. As it sits, only a few methods of treating autism are available.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment. The data is clear.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.

Medicine 81

Medicine Research and Development Data Policy 81

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. We have autism and epilepsy. Despite this, being in possession of a prescription is the only way that cannabis can be legally consumed.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Chronicles

JANUARY 2, 2019

drug regulators approved the first marijuana-based pharmaceutical to treat kids with a form of epilepsy, and billions of investment dollars poured into cannabis companies. It’s a non-psychoactive compound found in marijuana and hemp plants and used for treatment of certain medical problems. It’s not just the U.S.

Legalization 100

Legalization Research and Development Recreational Data 100

Cannabis Law Report

NOVEMBER 22, 2019

California’s Attorney General announced that the state’s Campaign Against Marijuana Planting program eradicated 953,459 cannabis plants from 345 raided grow sites across the state over the past year. New Mexico’s medical cannabis program generated $93.6 Enrollees are expected to top 80,000 patients by the end of the year.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

The Cannigma

SEPTEMBER 15, 2022

As our body of research expands, new avenues of potential treatment emerge for conditions that were previously overlooked. People with autism often have comorbid diagnoses such as anxiety, depression, sleep disturbances, ADHD, epilepsy, allergies, autoimmune conditions, and gastrointestinal conditions.

Terpenes 91

Terpenes Strains Sleep THC 91

Cannabis Law Report

SEPTEMBER 12, 2019

For those of you in the dark about Florida’s Medical Marijuana Program, I’ve been attempting to light up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times. What does it mean for Florida’s system, or for other states?

Seed-To-Sale 65

Seed-To-Sale Supply Chain Business Programs 65

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018.

Law 40

Law Seed-To-Sale Hemp Recreational 40